Is Tenable Stock a Buy, Sell or Hold?
Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…
Sell
46
HAS Quote, Financials, Valuation and Earnings
Last price:
$60.55
Seasonality move
:
10.32%
Day range:
$58.82 - $60.99
52-week range:
$54.05 - $73.46
Dividend yield:
4.63%
P/E ratio:
22.01x
P/S ratio:
2.05x
P/B ratio:
7.30x
Volume:
5.5M
Avg. volume:
2.1M
1-year change:
7.99%
Market cap:
$8.4B
Revenue:
$4.1B
EPS (TTM):
$2.75
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.5B | $6.4B | $5.9B | $5B | $4.1B | |
| Revenue Growth (YoY) | 15.79% | 17.47% | -8.78% | -14.57% | -17.35% | |
| Cost of Revenues | $2.3B | $2.5B | $2.4B | $2.1B | $1.5B | |
| Gross Profit | $3.2B | $3.9B | $3.5B | $2.9B | $2.7B | |
| Gross Profit Margin | 58.12% | 60.32% | 58.94% | 57.34% | 64.61% | |
| R&D Expenses | $259.5M | $315.7M | $307.9M | $306.9M | $294.1M | |
| Selling, General & Admin | $1.7B | $1.9B | $2.1B | $1.8B | $1.5B | |
| Other Inc / (Exp) | -$204.6M | -$115.9M | -$9.1M | -$1.7B | -$106.5M | |
| Operating Expenses | $2.5B | $3B | $3B | $2.7B | $1.9B | |
| Operating Income | $720.4M | $872.1M | $429.8M | $191.4M | $727.4M | |
| Net Interest Expenses | $193.7M | $174.3M | $159.2M | $163.3M | $123.9M | |
| EBT. Incl. Unusual Items | $322.1M | $581.9M | $261.5M | -$1.7B | $497M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $96.7M | $146.6M | $58.5M | -$221.3M | $102.6M | |
| Net Income to Company | $225.4M | $435.3M | $203M | -$1.5B | $394.4M | |
| Minority Interest in Earnings | -$2.9M | -$6.6M | $500K | -$1.5M | -$8.8M | |
| Net Income to Common Excl Extra Items | $222.5M | $428.7M | $203.5M | -$1.5B | $385.6M | |
| Basic EPS (Cont. Ops) | $1.62 | $3.11 | $1.47 | -$10.73 | $2.77 | |
| Diluted EPS (Cont. Ops) | $1.62 | $3.10 | $1.46 | -$10.73 | $2.75 | |
| Weighted Average Basic Share | $137.3M | $138M | $138.7M | $138.8M | $139.4M | |
| Weighted Average Diluted Share | $137.6M | $138.4M | $138.9M | $138.8M | $140.3M | |
| EBITDA | $1.2B | $1.7B | $1.2B | -$863.2M | $880.5M | |
| EBIT | $523.2M | $761.6M | $432.5M | -$1.5B | $668.2M | |
| Revenue (Reported) | $5.5B | $6.4B | $5.9B | $5B | $4.1B | |
| Operating Income (Reported) | $720.4M | $872.1M | $429.8M | $191.4M | $727.4M | |
| Operating Income (Adjusted) | $523.2M | $761.6M | $432.5M | -$1.5B | $668.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7B | $2B | $1.7B | $1.3B | $1.1B | |
| Revenue Growth (YoY) | 20.65% | 16.86% | -16.63% | -23.21% | -14.53% | |
| Cost of Revenues | $775.8M | $911.3M | $738.3M | $706.5M | $438.7M | |
| Gross Profit | $947.1M | $1.1B | $940.2M | $582.4M | $662.9M | |
| Gross Profit Margin | 54.97% | 54.74% | 56.01% | 45.19% | 60.18% | |
| R&D Expenses | $84.6M | $86.6M | $76.7M | $74.5M | $81.9M | |
| Selling, General & Admin | $467.7M | $578M | $776.3M | $539M | $466.3M | |
| Other Inc / (Exp) | -$54M | -$49.4M | $4.5M | -$1B | -$97.8M | |
| Operating Expenses | $708.2M | $923.6M | $1.1B | $755M | $590.1M | |
| Operating Income | $238.9M | $178.5M | -$126.7M | -$172.6M | $72.8M | |
| Net Interest Expenses | $46.3M | $41.2M | $42M | $38.9M | $32.2M | |
| EBT. Incl. Unusual Items | $138.6M | $87.9M | -$164.2M | -$1.2B | -$57.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $32.4M | $3.1M | -$35.6M | -$184.4M | -$30.7M | |
| Net Income to Company | $106.2M | $84.8M | -$128.6M | -$1.1B | -$26.5M | |
| Minority Interest in Earnings | -$1M | -$2.6M | -$300K | -$300K | -$7.8M | |
| Net Income to Common Excl Extra Items | $105.2M | $82.2M | -$128.9M | -$1.1B | -$34.3M | |
| Basic EPS (Cont. Ops) | $0.77 | $0.59 | -$0.93 | -$7.64 | -$0.25 | |
| Diluted EPS (Cont. Ops) | $0.76 | $0.59 | -$0.93 | -$7.64 | -$0.25 | |
| Weighted Average Basic Share | $137.6M | $137.7M | $138.1M | $139.1M | $139.7M | |
| Weighted Average Diluted Share | $137.9M | $138.1M | $138.3M | $139.1M | $141.2M | |
| EBITDA | $367.9M | $436.4M | $128.4M | -$1B | $48.9M | |
| EBIT | $186M | $130.3M | -$118.4M | -$1.2B | -$13.7M | |
| Revenue (Reported) | $1.7B | $2B | $1.7B | $1.3B | $1.1B | |
| Operating Income (Reported) | $238.9M | $178.5M | -$126.7M | -$172.6M | $72.8M | |
| Operating Income (Adjusted) | $186M | $130.3M | -$118.4M | -$1.2B | -$13.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.5B | $6.4B | $5.9B | $5B | $4.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.3B | $2.5B | $2.4B | $2.1B | $1.5B | |
| Gross Profit | $3.2B | $3.9B | $3.5B | $2.9B | $2.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $259.5M | $315.7M | $307.9M | $306.9M | $294.1M | |
| Selling, General & Admin | $1.7B | $1.9B | $2.1B | $1.8B | $1.5B | |
| Other Inc / (Exp) | -$204.6M | -$115.9M | -$9.1M | -$1.7B | -$106.5M | |
| Operating Expenses | $2.5B | $3B | $3B | $2.7B | $1.9B | |
| Operating Income | $720.4M | $872.1M | $429.8M | $191.4M | $727.4M | |
| Net Interest Expenses | $193.7M | $174.3M | $159.2M | $163.3M | $123.9M | |
| EBT. Incl. Unusual Items | $322.1M | $581.9M | $261.5M | -$1.7B | $497M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $96.7M | $146.6M | $58.5M | -$221.3M | $102.6M | |
| Net Income to Company | $225.4M | $435.3M | $203M | -$1.5B | $394.4M | |
| Minority Interest in Earnings | -$2.9M | -$6.6M | $500K | -$1.5M | -$8.8M | |
| Net Income to Common Excl Extra Items | $222.5M | $428.7M | $203.5M | -$1.5B | $385.6M | |
| Basic EPS (Cont. Ops) | $1.62 | $3.09 | $1.46 | -$10.72 | $2.76 | |
| Diluted EPS (Cont. Ops) | $1.61 | $3.09 | $1.46 | -$10.72 | $2.75 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $1.2B | $1.7B | $1.2B | -$863.2M | $880.5M | |
| EBIT | $523.2M | $761.6M | $432.5M | -$1.5B | $668.2M | |
| Revenue (Reported) | $5.5B | $6.4B | $5.9B | $5B | $4.1B | |
| Operating Income (Reported) | $720.4M | $872.1M | $429.8M | $191.4M | $727.4M | |
| Operating Income (Adjusted) | $523.2M | $761.6M | $432.5M | -$1.5B | $668.2M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6.4B | $5.9B | $5B | $4.1B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.5B | $2.4B | $2.1B | $1.5B | -- | |
| Gross Profit | $3.9B | $3.5B | $2.9B | $2.7B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $315.7M | $307.9M | $306.9M | $294.1M | -- | |
| Selling, General & Admin | $1.9B | $2.1B | $1.8B | $1.5B | -- | |
| Other Inc / (Exp) | -$115.9M | -$9.1M | -$1.7B | -$106.5M | -- | |
| Operating Expenses | $3B | $3B | $2.7B | $1.9B | -- | |
| Operating Income | $872.1M | $429.8M | $191.4M | $727.4M | -- | |
| Net Interest Expenses | $174.3M | $159.2M | $163.3M | $123.9M | -- | |
| EBT. Incl. Unusual Items | $581.9M | $261.5M | -$1.7B | $497M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $146.6M | $58.5M | -$221.3M | $102.6M | -- | |
| Net Income to Company | $435.3M | $203M | -$1.5B | $394.4M | -- | |
| Minority Interest in Earnings | -$6.6M | $500K | -$1.5M | -$8.8M | -- | |
| Net Income to Common Excl Extra Items | $428.7M | $203.5M | -$1.5B | $385.6M | -- | |
| Basic EPS (Cont. Ops) | $3.09 | $1.46 | -$10.72 | $2.76 | -- | |
| Diluted EPS (Cont. Ops) | $3.09 | $1.46 | -$10.72 | $2.75 | -- | |
| Weighted Average Basic Share | $551.5M | $554.7M | $555.3M | $557.8M | -- | |
| Weighted Average Diluted Share | $552.5M | $555.6M | $555.3M | $561M | -- | |
| EBITDA | $1.7B | $1.2B | -$863.2M | $880.5M | -- | |
| EBIT | $761.6M | $432.5M | -$1.5B | $668.2M | -- | |
| Revenue (Reported) | $6.4B | $5.9B | $5B | $4.1B | -- | |
| Operating Income (Reported) | $872.1M | $429.8M | $191.4M | $727.4M | -- | |
| Operating Income (Adjusted) | $761.6M | $432.5M | -$1.5B | $668.2M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.4B | $983.4M | $498.6M | $544.8M | $694.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.4B | $1.5B | $1.1B | $1B | $919.8M | |
| Inventory | $395.6M | $552.1M | $676.8M | $332M | $274.2M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $609.6M | $656.4M | $676.8M | $416.9M | $353.5M | |
| Total Current Assets | $3.8B | $3.7B | $3B | $2.3B | $2.2B | |
| Property Plant And Equipment | $489M | $421.1M | $422.8M | $334.3M | $302.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $3.7B | $3.4B | $3.5B | $2.3B | $2.3B | |
| Other Intangibles | $1.5B | $1.2B | $814.6M | $587.5M | $518.4M | |
| Other Long-Term Assets | $1.3B | $1.3B | $1.6B | $1B | $998.6M | |
| Total Assets | $10.8B | $10B | $9.3B | $6.5B | $6.3B | |
| Accounts Payable | $425.5M | $580.2M | $427.3M | $340.6M | $341.5M | |
| Accrued Expenses | $1.1B | $1.3B | $1B | $742.8M | $715.6M | |
| Current Portion Of Long-Term Debt | -- | $200.9M | $255.6M | $500M | -- | |
| Current Portion Of Capital Lease Obligations | -- | $43.9M | $39.6M | $30.5M | $29.8M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2.4B | $2.5B | $2.2B | $2.1B | $1.4B | |
| Long-Term Debt | $4.7B | $3.8B | $3.7B | $3B | $3.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $7.9B | $7B | $6.4B | $5.5B | $5.2B | |
| Common Stock | $110.1M | $110.1M | $110.1M | $110.1M | $110.1M | |
| Other Common Equity Adj | -$195M | -$235.3M | -$254.9M | -$201.5M | -$246.4M | |
| Common Equity | $2.9B | $3B | $2.8B | $1.1B | $1.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $64.4M | $61.1M | $29.1M | $25.1M | $27.4M | |
| Total Equity | $3B | $3.1B | $2.9B | $1.1B | $1.2B | |
| Total Liabilities and Equity | $10.8B | $10B | $9.3B | $6.5B | $6.3B | |
| Cash and Short Terms | $1.4B | $983.4M | $498.6M | $544.8M | $694.7M | |
| Total Debt | $5.1B | $4B | $4B | $3.5B | $3.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.4B | $983.4M | $498.6M | $544.8M | $694.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.4B | $1.5B | $1.1B | $1B | $919.8M | |
| Inventory | $395.6M | $552.1M | $676.8M | $332M | $274.2M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $609.6M | $656.4M | $676.8M | $416.9M | $353.5M | |
| Total Current Assets | $3.8B | $3.7B | $3B | $2.3B | $2.2B | |
| Property Plant And Equipment | $489M | $421.1M | $422.8M | $334.3M | $302.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $3.7B | $3.4B | $3.5B | $2.3B | $2.3B | |
| Other Intangibles | $1.5B | $1.2B | $814.6M | $587.5M | $518.4M | |
| Other Long-Term Assets | $1.3B | $1.3B | $1.6B | $1B | $998.6M | |
| Total Assets | $10.8B | $10B | $9.3B | $6.5B | $6.3B | |
| Accounts Payable | $425.5M | $580.2M | $427.3M | $340.6M | $341.5M | |
| Accrued Expenses | $1.1B | $1.3B | $1B | $742.8M | $715.6M | |
| Current Portion Of Long-Term Debt | -- | $200.9M | $255.6M | $500M | -- | |
| Current Portion Of Capital Lease Obligations | -- | $43.9M | $39.6M | $30.5M | $29.8M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2.4B | $2.5B | $2.2B | $2.1B | $1.4B | |
| Long-Term Debt | $4.7B | $3.8B | $3.7B | $3B | $3.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $7.9B | $7B | $6.4B | $5.5B | $5.2B | |
| Common Stock | $110.1M | $110.1M | $110.1M | $110.1M | $110.1M | |
| Other Common Equity Adj | -$195M | -$235.3M | -$254.9M | -$201.5M | -$246.4M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $64.4M | $61.1M | $29.1M | $25.1M | $27.4M | |
| Total Equity | $3B | $3.1B | $2.9B | $1.1B | $1.2B | |
| Total Liabilities and Equity | $10.8B | $10B | $9.3B | $6.5B | $6.3B | |
| Cash and Short Terms | $1.4B | $983.4M | $498.6M | $544.8M | $694.7M | |
| Total Debt | $5.1B | $4B | $4B | $3.5B | $3.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $225.4M | $435.3M | $203M | -$1.5B | $394.4M | |
| Depreciation & Amoritzation | $652M | $908.7M | $788.1M | $659.6M | $212.3M | |
| Stock-Based Compensation | $49.7M | $97.8M | $83.4M | $72.4M | $50.8M | |
| Change in Accounts Receivable | $210.8M | -$159.5M | $339.6M | $15.5M | $77.3M | |
| Change in Inventories | $62.8M | -$182.3M | -$184.7M | $257.1M | $22.1M | |
| Cash From Operations | $976.3M | $817.9M | $372.9M | $725.6M | $847.4M | |
| Capital Expenditures | $125.8M | $132.7M | $174.2M | $209.3M | $197.5M | |
| Cash Acquisitions | -- | $378.5M | -$146.3M | $329.6M | -$12M | |
| Cash From Investing | -$4.5B | $242M | -$313M | $117.6M | -$203.7M | |
| Dividends Paid (Ex Special Dividend) | -$372.7M | -$374.5M | -$385.3M | -$388M | -$389.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.1B | $144M | $3.8M | $2.6M | $498.6M | |
| Long-Term Debt Repaid | -$284.1M | -$1.2B | -$206M | -$359.6M | -$581.3M | |
| Repurchase of Common Stock | -$47.4M | -- | -$125M | -- | -- | |
| Other Financing Activities | -$19.1M | -$34.2M | -$56.7M | -$31.5M | -$27.2M | |
| Cash From Financing | $405.9M | -$1.5B | -$553.3M | -$818.1M | -$497.5M | |
| Beginning Cash (CF) | $4.6B | $1.4B | $1B | $513.1M | $545.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$3.1B | -$399.9M | -$493.4M | $25.1M | $146.2M | |
| Ending Cash (CF) | $1.4B | $1B | $513.1M | $545.4M | $695M | |
| Levered Free Cash Flow | $850.5M | $685.2M | $198.7M | $516.3M | $649.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $106.2M | $84.8M | -$128.6M | -$1.1B | -$26.5M | |
| Depreciation & Amoritzation | $181.9M | $306.1M | $246.8M | $181.2M | $62.6M | |
| Stock-Based Compensation | $9.7M | $41.6M | $17.2M | $16.5M | $22M | |
| Change in Accounts Receivable | $45.2M | -$75.7M | $137.8M | $101.8M | $127M | |
| Change in Inventories | $159.7M | -$22.9M | $142.5M | $204.1M | $67.6M | |
| Cash From Operations | $482M | $132.3M | $110.7M | $390.7M | $259.8M | |
| Capital Expenditures | $33.7M | $34.6M | $43.5M | $48.9M | $51.3M | |
| Cash Acquisitions | $4.4B | -$700K | -- | $329.6M | -- | |
| Cash From Investing | -$28.5M | -$35.5M | -$47.2M | $280.2M | $431.7M | |
| Dividends Paid (Ex Special Dividend) | -$93.3M | -$93.8M | -$96.7M | -$97.1M | -$97.7M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $76.6M | $16.4M | -$121.1M | -$200K | -- | |
| Long-Term Debt Repaid | -$136.5M | -$151.8M | -$24M | -$252.6M | -$581.3M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$6.2M | -$7.5M | -$10.2M | -$8.6M | -$4M | |
| Cash From Financing | -$144.6M | -$236.3M | -$110.3M | -$400.1M | -$688.3M | |
| Beginning Cash (CF) | $1.1B | $1.2B | $551.6M | $185.5M | $696.1M | |
| Foreign Exchange Rate Adjustment | $8.4M | -$22.5M | $3.5M | $18.7M | -$4.3M | |
| Additions / Reductions | $308.9M | -$139.5M | -$46.8M | $270.8M | $3.2M | |
| Ending Cash (CF) | $1.4B | $1B | $513.1M | $545.4M | $695M | |
| Levered Free Cash Flow | $448.3M | $97.7M | $67.2M | $341.8M | $208.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $225.4M | $435.3M | $203M | -$1.5B | $394.4M | |
| Depreciation & Amoritzation | $652M | $908.7M | $788.1M | $659.6M | $212.3M | |
| Stock-Based Compensation | $49.7M | $97.8M | $83.4M | $72.4M | $50.8M | |
| Change in Accounts Receivable | $210.8M | -$159.5M | $339.6M | $15.5M | $77.3M | |
| Change in Inventories | $62.8M | -$182.3M | -$184.7M | $257.1M | $22.1M | |
| Cash From Operations | $976.3M | $817.9M | $372.9M | $725.6M | $847.4M | |
| Capital Expenditures | $125.8M | $132.7M | $174.2M | $209.3M | $197.5M | |
| Cash Acquisitions | -- | $378.5M | -$146.3M | $329.6M | -$12M | |
| Cash From Investing | -$4.5B | $242M | -$313M | $117.6M | -$203.7M | |
| Dividends Paid (Ex Special Dividend) | -$372.7M | -$374.5M | -$385.3M | -$388M | -$389.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.1B | $144M | $3.8M | $2.6M | $498.6M | |
| Long-Term Debt Repaid | -$284.1M | -$1.2B | -$206M | -$359.6M | -$581.3M | |
| Repurchase of Common Stock | -$47.4M | -- | -- | -- | -- | |
| Other Financing Activities | -$19.1M | -$34.2M | -$56.7M | -$31.5M | -$27.2M | |
| Cash From Financing | $405.9M | -$1.5B | -$553.3M | -$818.1M | -$497.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$3.1B | -$399.9M | -$493.4M | $25.1M | $146.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $850.5M | $685.2M | $198.7M | $516.3M | $649.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $435.3M | $203M | -$1.5B | $394.4M | -- | |
| Depreciation & Amoritzation | $908.7M | $788.1M | $659.6M | $212.3M | -- | |
| Stock-Based Compensation | $97.8M | $83.4M | $72.4M | $50.8M | -- | |
| Change in Accounts Receivable | -$159.5M | $339.6M | $15.5M | $77.3M | -- | |
| Change in Inventories | -$182.3M | -$184.7M | $257.1M | $22.1M | -- | |
| Cash From Operations | $817.9M | $372.9M | $725.6M | $847.4M | -- | |
| Capital Expenditures | $132.7M | $174.2M | $209.3M | $197.5M | -- | |
| Cash Acquisitions | $378.5M | -$146.3M | $329.6M | -$12M | -- | |
| Cash From Investing | $242M | -$313M | $117.6M | -$203.7M | -- | |
| Dividends Paid (Ex Special Dividend) | -$374.5M | -$385.3M | -$388M | -$389.9M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $144M | $3.8M | $2.6M | $498.6M | -- | |
| Long-Term Debt Repaid | -$1.2B | -$206M | -$359.6M | -$581.3M | -- | |
| Repurchase of Common Stock | -- | -$125M | -- | -- | -- | |
| Other Financing Activities | -$34.2M | -$56.7M | -$31.5M | -$27.2M | -- | |
| Cash From Financing | -$1.5B | -$553.3M | -$818.1M | -$497.5M | -- | |
| Beginning Cash (CF) | $5.3B | $3.3B | $1.3B | $2.4B | -- | |
| Foreign Exchange Rate Adjustment | -$30.6M | -$12.7M | $7.2M | $3.4M | -- | |
| Additions / Reductions | -$399.9M | -$493.4M | $25.1M | $146.2M | -- | |
| Ending Cash (CF) | $4.9B | $2.8B | $1.3B | $2.6B | -- | |
| Levered Free Cash Flow | $685.2M | $198.7M | $516.3M | $649.9M | -- | |
Get HAS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HAS
Sector
P/E ratio
22.01x
16.26x
PEG ratio
-0.95x
0.19x
P/B ratio
7.30x
1.39x
Price / LTM sales
2.05x
0.66x
Growth Metrics
HAS
Sector
Revenue growth
-14.53%
1.82%
Earnings growth
--
0.82%
Revenue (5-year growth)
-2.61%
3.61%
Earnings forecast
$0.35
$0.30
Profitability
HAS
Sector
Profitability FY 2024
$2.7B
$485.8M
Return on invested capital
8.03%
4.91%
Return on assets
5.81%
3.03%
Return on equity
33.33%
7.42%
Earnings Date
Last Earnings Date
Feb
20
Next Earnings Date
Apr
24
Estimated Next Earnings Date
May
22
Balance Sheet
HAS
Sector
Total cash
$694.7M
$157.2M
Short term investments
--
$56.5M
Total assets
$6.3B
$1.6B
Long term debt
$3.4B
$156.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 24
Regencell Bioscience Holdings [RGC] is down 18.13% over the past day.
Sell
36
VMI alert for Mar 24
Valmont Industries [VMI] is up 5.46% over the past day.
Buy
61
ALNY alert for Mar 24
Alnylam Pharmaceuticals [ALNY] is up 5.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
